HIV-HCV co-infected patients
Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients
... (HCV) patients. The aim of the study was to assess MT in plasma of HIV-HCV co-infected ...in HIV-HCV co-infected patients than in healthy ...
11
HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort)
... Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort) Melina Erica Santos, Camelia Protopopescu, Philippe Sogni, Issifou ...
50
Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients.
... western patients with HCV ...to patients co-infected with HIV and HCV may re- sult in ...for co-infected ...
9
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).
... of HIV- HCV infected patients enrolled and followed up in France shows that barriers to HCV treatment do not solely depend on patient characteristics and physicians’ perceptions of ...
12
Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.: Non invasive fibrosis indexes in HIV-HCV coinfected patients
... many patients are reluctant to undergo liver biopsies and HIV-HCV coinfected patients may be discouraged to start anti-HCV treatment for this ...in HCV monoinfected ...
24
Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort
... population, HIV-infected patients are at higher risk of developing non-AIDS-defining ...Chronic HCV infection has also been associated with a higher risk than that of the general population of ...
12
Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS CO-13 HEPAVIH Cohort)
... on patients with chronic hepatitis C which also showed an inverse relationship between coffee intake and the risk of liver fibrosis [ 7 , 31 , 32 ...in HIV-HCV co-infected ...
18
Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.
... antly infected with genotype-HCV 1, hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors particu- larly in ...
11
Distributive sharing among HIV-HCV co-infected injecting drug users: the preventive role of trust in one's physician
... of HCV in injecting drug users (IDUs) remains extremely high (60-70%) and even higher in those HIV-infected through drug use (Jauffret-Roustide et ...IDUs, HCV, like HIV, is mainly ...
17
CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART
... among HIV-infected patients but its repercus- sion on the course of CD4+ and CD8+ T cells after cART initiation remains ...5,688 patients on first-line cART, from which we selected ...
13
Cystatin C in HIV-infected patients: promising but not yet ready for prime time.
... to HIV infection that may influence creatinine level, two recent US cohort studies have compared serum creatinine in HIV and control non- HIV ...519 HIV-positive patients were com- ...
9
Impact of HCV treatment and depressive symptoms on adherence to HAART among coinfected HIV-HCV patients: results from the ANRS-CO13-HEPAVIH cohort.
... (visits were annual) that included items on socio-demographic characteristics, past and current drug and alcohol use, treatment history, HAART adherence and psychosocial factors. Clinical and biological data, including ...
24
Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.
... that HIV treatments may generate drug side ...APROCO patients showed that they retained the notion of direct individual benefit as the possibility to gain a treatment adapted to their own (data not ...
19
PLA2G1B is involved in CD4 anergy and CD4 lymphopenia in HIV-infected patients
... Figure 8. Synergy between PLA2G1B activity and gp41. (A, B) ELISA quantification of PLA2G1B in plasma from HD, VP, HIV-controllers (HIC) and ART-treated donors (ART) (median is shown). The Kruskal-Wallis test ...
51
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
... all patients were receiving cART at the time of the study but only ...the patients, due to the increase in tenofovir AUC expected when combining both drugs [ 18 , 19 ...all patients but would have ...
14
Hierarchy of Determinants Underlying Death among HIV-Infected Patients in French Guiana
... Citation: Hanf M, Adenis A, Carme B, Couppié P, Nacher M (2012) Hierarchy of Determinants Underlying Death among HIV-Infected Patients in French Guiana. J AIDS Clinic Res 3:172. doi : ...
5
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.
... than HIV infection? Few data are available for sub-Saharan ...these patients and populations exposed to risk factors are thus quite comparable to those found in some of the patient groups included in our ...
11
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study
... in HCV patients with B-NHL is ...61 HCV patients with B- NHL enrolled in a nationwide observational survey compared with 94 matched HCV- infected controls without ...10 ...
17
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.
... Some patients had missing data at baseline for CD4 cell count or clinical ...among patients with more than 50 cells/ µ ...to patients and type of follow-up (active tracing of patients versus ...
27
Incidence and Risk Factors for Follow-Up Interruption of HIV-Infected Patients in Guadeloupe
... foreign HIV patients returned to their country of ...some patients may have consulted a practitioner who is not included in the FHDH, the increased risk of permanent loss to follow-up in untreated ...
5